The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead 2vt Regulatory News (BMD)

Share Price Information for Baronsmead 2vt (BMD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 55.00
Bid: 53.50
Ask: 56.50
Change: 0.00 (0.00%)
Spread: 3.00 (5.607%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 55.00
BMD Live PriceLast checked at -
Baronsmead Second Venture Trust is an Investment Trust

To achieve long-term investment returns for private investors by investing primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

18 Aug 2015 16:40

RNS Number : 4105W
Baronsmead VCT 3 PLC
18 August 2015
 

Baronsmead VCT 3 plc

Half-yearly report for the six months ended

30 June 2015

 

The Directors announce the audited half-yearly financial report for the six months to 30 June 2015 as follows:-

 

Copies of the half-yearly report can be obtained from the following website: www.baronsmeadvct3.co.uk.

 

Our Investment Objective

 

Baronsmead VCT 3 is a tax efficient listed Company which aims to achieve long-term investment returns for private investors.

 

Investment Policy

 

· To invest primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM

· Investments are made selectively across a range of sectors in companies that have the potential to grow and enhance their value.

 

Dividend Policy

 

The Board of Baronsmead VCT 3 has the objective to maintain a minimum annual dividend level of around 4.5p per ordinary share if possible, but this depends primarily on the level of realisations achieved and cannot be guaranteed.

 

Shareholder choice

 

The Board wishes to provide shareholders with a number of choices that enable them to utilise their investment in Baronsmead VCT 3 in ways that best suit their personal investment and tax planning and in a way that treats all shareholders equally.

 

· Fund raising | From time to time the Company seeks to raise additional funds by issuing new shares at a premium to the latest published net asset value to account for issue costs.

 

· Dividend Reinvestment Plan | The Company offers a Dividend Reinvestment Plan which enables shareholders to purchase additional shares through the market in lieu of cash dividends.

 

· Buy back of shares | From time to time the Company buys its own shares through the market in accordance with its share price discount policy. Subject to certain conditions, the Company seeks to maintain a mid market share price discount of approximately 5 per cent. to net asset value. In the six months to 30 June 2015, 1,065,000 shares were bought back representing 1.4 per cent. of the shares in issue (excluding treasury shares) at 30 June 2015 at prices which represent an average of 5.1 per cent. discount to the latest published net asset values at the time the shares were bought back.

 

· Secondary market | The Company's shares are listed on the London Stock Exchange and can be bought using a stockbroker or authorised share dealing service in the same way as shares of any other listed company. Approximately 164,000 existing shares were bought by investors in the six months to 30 June 2015.

 

Financial Headlines

 

· + 5.5% - Net asset value ("NAV") per share increased 5.5 per cent to 107.35p in the six months to 30 June 2015, before deduction of dividends.

 

· 271.4p - NAV total return to shareholders for every 100.0p invested at launch.

 

· 3.0p - Interim dividend of 3.0p for the six month period to 30 June 2015 to be paid on 18 September 2015.

 

· £4.7m - Total divestments made of £2.2m unquoted and £2.5m quoted in the six months to 30 June 2015.

 

Cash Returned to Shareholders by date of investment

 

The table below shows the cash returned to shareholders, dependent on their subscription cost, including their income tax reclaimed on subscription.

Year subscribed

Cash invested (p)

Income taxreclaim

(p)

Net cashinvested (p)

Cumulative dividends paid (p)*

Return on cash invested (%)

2001 (January)

100.00

20.00

80.00

98.30

118.3

2005 (March) - C share**

100.00

40.00

60.00

62.67

102.7

2010 (March)

103.09

30.93

72.16

50.00

78.5

2012 (December)

117.40

35.22

82.18

32.00

57.3

2014 (March)

112.40

33.70

78.70

12.00

40.7

 

Note - The total return could be higher for those shareholders who were able to defer a capital gain on subscription and the net sum invested may be less.

 

* Includes 3.0p interim dividend payable on 18 September 2015.

** Dividends paid to C shareholders post conversion have been adjusted by the conversion ratio (0.85642528).

 

Chairman's Statement

 

I am pleased to report an increase of 5.6p (5.5 per cent.) in the underlying NAV per share for the six months to 30 June 2015. This was attributable to increases in valuation of both the unquoted and quoted portfolios.

The interim dividend of 3.0p per share will be paid on 18 September 2015 to shareholders on the register as at 4 September 2015.

 

Results

 

During the six months to 30 June 2015, the Company's NAV per share increased 5.5 per cent. from 101.72p to 107.35p before taking dividends into account.

 

 

p perordinaryshare

NAV as at 1 January 2015

101.72

Valuation uplift (5.5 per cent.)

5.63

NAV as at 30 June 2015 before dividends

107.35

Less:

Interim dividend payable on 18 September 2015

(3.00)

NAV as at 30 June 2015 after accounting for interim dividend

104.35

 

Portfolio Review

 

As shown in the table below, as at 30 June 2015 the Company's net assets of £79.7m were invested directly or indirectly in 107 companies. This table also shows that the main driver of the growth in the value of the NAV over the period was the 12.6 per cent. increase in the value of the unquoted portfolio along with positive contributions from the Company's quoted investments.

 

Asset class

NAV (£m)

% of net assets*

No. of investees

% return over the period

Unquoted companies

29.2

37

24

12.6**

AIM traded companies

24.8

31

45

3.0

Wood Street Microcap Investment Fund

8.5

11

38

10.6

Other net assets, primarily cash and fixed interest

17.2

21

N/A

-

Totals

79.7

100

107

 

 

* By value as at 30 June 2015.

** Includes capitalised interest and redemption premium income received.

 

Investment and Divestment Activity

 

The Company invested £4.7m in four new unquoted and four new quoted companies. Smaller follow-on investments in four quoted companies totalled £0.8m. Three of the new unquoted investments were in "acquisition" companies formed to enable investments into established trading entities over the next two years. The other new unquoted investment was in Centre4 Testing which is a specialist provider of software testing services that helps its clients to manage software implementations, upgrades and integration.

 

A total of £4.7m was realised from the five full and several partial sales of investments and loan note redemptions. From the unquoted portfolio, the sale of the Company's investment in Luxury For Less generated a return 2.0 times its original cost within a relatively short investment period of 20 months. From the quoted portfolio, a longer term investment in Accumuli generated a return 4.4 times its original cost over 4.5 years.

 

Against these successes, losses were realised on other investments; notably, Impetus Holdings and Surgi C. While it is disappointing to have poor realisations, it is in the nature of private equity investment that some investments will fail to achieve their full potential. However, these realisations had no impact on the NAV at 30 June 2015 as the Board had made full provisions against the value of these investments in earlier periods. More positively, the Investment Manager has continued to consolidate the gains achieved in the quoted portfolio with the Accumuli realisation referred to above being the most notable.

 

The tables below provide further information concerning the Company's investments and divestments during the period.

 

Long Term Performance

 

The Company's objective continues to be focused on generating consistent returns over the long-term through investing in a portfolio of small unquoted and AIM traded companies with strong growth prospects.

Baronsmead VCT 3 has been investing funds for shareholders since 2001 and, despite the inherent risk of investing in small companies, the trust has delivered consistently good returns for investors. While VCT tax reliefs do not change the underlying risks associated with investing in smaller companies, the upfront tax relief and the payment of tax free dividends helps to lessen the amount of shareholders original investment cost which remains "at risk".

 

As shown in the table above those shareholders who subscribed for shares in the Company's fundraisings in January 2001 and March 2005 have had their entire investment returned in dividends and reliefs. For instance, since investing 100p in 2001, founder shareholders have received cash payments totalling 118.3p (being 20p VCT income tax relief and 98.3p in dividends) and they still have an investment in the trust with a NAV of 104.35p per share (after accounting for the interim dividend).

 

While this analysis does not take account of the on-going value of the tax free nature of VCT dividends, it serves as a useful indicator of investment performance over the long term and the cumulative cash that has been returned to shareholders.

 

VCT LEGISLATION

 

In the successive March and Summer Budgets 2015, the Chancellor announced legislative changes that are designed to ensure that VCTs continue to be approved by the European Union ("EU") and remain effective in giving small and growing businesses access to finance. In order to meet EU requirements the UK Government has proposed introducing new criteria regarding the age of companies that will be eligible as investments, a lifetime cap on the total amount of state aided investment that an investee company can receive and rules that require that the investment be used for the "organic" growth of the investee company. The legislation is subject to EU State aid approval and is expected to take effect from the date of Royal Assent later this year.

 

The objective of these changes is to direct VCT investments into younger companies that will use the investment to grow their businesses "organically" rather than acquiring another business or trade. The Manager believes that if the proposed legislation is enacted by the UK as drafted it will present a number of challenges for the VCT industry. However, the Manager, with its long track record of successful investing and experienced team, should be well placed to adapt to these new rules. As the draft legislation is complex it is not yet entirely clear how the rules will affect the VCT industry but we expect to be able to provide an update in the next quarter.

 

Outlook

 

The improvement in the UK economy now appears to be more firmly established. However, the UK economy does not operate in isolation and the external environment remains uncertain with concerns over the on-going issues related to Greece and the Eurozone countries, growth and stock market valuations in China and continued political instability in various regions.

 

The unquoted portfolio contains a higher proportion of newer investments following recent sales. As a result, growth in the value of the unquoted portfolio is likely to be more modest until these investments mature, although some increase in value has begun to take place. The progress made by our newer investments and the Company's portfolio diversity and asset mix should help to continue to deliver consistent returns for shareholders.

 

Anthony Townsend

Chairman

18 August 2015

Table of Investments and Realisations

 

Investments in the period

Company

Location

Sector

Activity

Book cost £'000

Unquoted investments

New

Ingleby (1973) Ltd

London

Business Services

Company seeking to acquire businesses in the Business Services sector

956

Ingleby (1974) Ltd

London

Business Services

Company seeking to acquire businesses in the Business Services sector

956

Ingleby (1975) Ltd

London

Consumer Markets

Company seeking to acquire businesses in the Consumer Markets sector

956

Centre4 Testing Ltd

Sussex

Business Services

Provider of software testing services, primarily through use of contractors

954

Total unquoted investments

3,822

AIM traded investments

New

CentralNic Group plc

London

TMT*

Provider of domain name & registry services

396

Venn Life SciencesHoldings plc

London

Healthcare & Education

Clinical Research organisation providing consulting and clinical trial services

225

Plant Impact plc

Hertfordshire

Business Services

Crop enhancing products

189

MXC Capital Ltd

Guernsey

Business Services

Tech focused investor & advisory business

112

Follow on

 

 

 

 

Ideagen plc

Derbyshire

TMT*

Compliance software solutions

450

EG Solutions plc#

Staffordshire

TMT*

Back office optimisation software

228

Pinnacle TechnologyGroup plc

Stirlingshire

TMT*

B2B telecoms and IT reseller

50

Castleton Technology plc

Cambridge

TMT*

Public sector IT managed services and software

33

Total AIM traded investments

1,683

Total investments in the period

5,505

 

* Technology, Media & Telecommunications ("TMT").

# During the period, the EG Solutions plc Loan note and capitalised interest was converted into Ordinary shares.

Realisations in the period

Company

 

First

investment

date

Book cost

£'000

Proceeds‡

£'000

Overall

multiple

return*

Unquoted realisations

Luxury For Less Ltd

Full trade sale

Jul 13

955

1,787

2.0

Create Health Ltd

Loan repayment

Mar 13

112

213

1.9

Eque2 Ltd

Loan repayment

Apr 13

111

123

1.1

Kingsbridge Ltd

Loan repayment

Jan 14

48

76

1.6

Impetus Holdings Ltd

Full trade sale

Apr 12

1,305

0

0.0

Surgi C Ltd

Full trade sale

Apr 10

853

0

0.3

Total unquoted realisations

3,384

2,199

 

AIM traded realisations

Accumuli plc

Recommended offer

Nov 10

505

2,140

4.4

Anpario plc

Market sale

Nov 06

54

235

4.3

Cohort plc

Full market sale

Oct 07

48

76

1.7

Total AIM traded realisations

607

2,451

 

Total realisations in the period

3,991

4,650†

 

‡ Proceeds at time of realisation including redemption premium and interest.

* Includes interest/dividends received, loan note redemptions and partial realisations accounted for in prior periods.

† Proceeds of £39,000 were also received in respect of MLS Ltd and £5,000 in respect of Playforce Holdings Ltd, both of which had be sold in prior periods. Deferred consideration of £88,000 was also received in respect of CSC (World) Ltd.

 

Summary Investment Portfolio

 

Investment Diversification at 30 June 2015

 

 

Sector by value

 

Percentage

 

 

Business Services

41%

Consumer Markets

17%

Healthcare & Education

10%

Technology, Media & Telecommunications ("TMT")

32%

 

 

Total assets by value

 

Percentage

 

 

Unquoted - loan note

25%

Unquoted - equity

12%

AIM & collective investment vehicle

42%

Listed interest bearing securities

10%

Net current assets (principally cash)

11%

 

Time investments held by value

 

Percentage

 

 

Less than 1 year

17%

Between 1 and 3 years

26%

Between 3 and 5 years

20%

Greater than 5 years

37%

 

Independent Review Report to Baronsmead VCT 3 plc

 

Introduction

 

We have been engaged by the Company to review the condensed set of financial statements in the half-yearly financial report for the six months ended 30 June 2015 which comprises the Income Statement, Statement of Changes in Equity, Balance Sheet and Statement of Cash Flows and the related explanatory notes. We have read the other information contained in the half-yearly financial report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements.

 

This report is made solely to the Company in accordance with the terms of our engagement to assist the Company in meeting the requirements of the Disclosure and Transparency Rules ("the DTR") of the UK's Financial Conduct Authority ("the UK FCA"). Our review has been undertaken so that we might state to the Company those matters we are required to state to it in this report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company for our review work, for this report, or for the conclusions we have reached.

 

Directors' responsibilities

 

The half-yearly financial report is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the half-yearly financial report in accordance with the DTR of the UK FCA.

 

As disclosed in note 1, the annual financial statements of the Company will be prepared in accordance with UK Accounting Standards and applicable law (UK Generally Accepted Accounting Practice), including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland. The condensed set of financial statements included in this half-yearly financial report has been prepared in accordance with FRS 104 Interim Financial Reporting.

 

Our responsibility

 

Our responsibility is to express to the Company a conclusion on the condensed set of financial statements in the half-yearly financial report based on our review.

 

Scope of review

 

We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410 Review of Interim Financial Information Performed by the Independent Auditor of the Entity issued by the Auditing Practices Board for use in the UK. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK and Ireland) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

 

Conclusion

 

Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the half-yearly financial report for the six months ended 30 June 2015 is not prepared, in all material respects, in accordance with FRS 104 Interim Financial Reporting and the DTR of the UK FCA.

 

Catherine Burnet

for and on behalf of KPMG LLPChartered AccountantsSaltire Court20 Castle TerraceEdinburgh EH1 2EG18 August 2015

 

Responsibility statement of the Directors in respect of the half-yearly financial report

 

We confirm that to the best of our knowledge:

· the condensed set of financial statements has been prepared in accordance with the FRS104 'Interim Financial Reporting';

 

· the Chairman's Statement (constituting the interim management report) includes a fair review of the information required by DTR 4.2.7R of the Disclosure and Transparency Rules, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements;

 

· the Statement of Principal Risks and Uncertainties below is a fair review of the information required by DTR 4.2.7R being a description of the principal risks and uncertainties for the remaining six months of the year; and

 

· the financial statements include a fair review of the information required by DTR 4.2.8R of the Disclosure and Transparency Rules, being related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the Company during that period; and any changes in the related party transactions described in the last annual report that could do so.

 

On behalf of the Board

Anthony Townsend

Chairman

18 August 2015

 

Unaudited Income Statement

For the six months to 30 June 2015

 

 

 

Six months to30 June 2015

Six months to30 June 2014

Year to31 December 2014

 

 

Notes

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

 

 

 

 

 

 

 

 

 

 

 

Unrealised gains on movement

in fair value of investments

 

7

-

4,142

4,142

-

3,285

3,285

-

2,443

2,443

 

Realised gains on disposalof investments

 

 

7

-

473

473

-

323

323

-

957

957

 

Income

 

711

-

711

790

-

790

2,591

-

2,591

 

Investment management fee

 

(233)

(700)

(933)

(232)

(697)

(929)

(461)‌‌

(1,381)‌‌

(1,842)‌‌

Other expenses

 

(246)

-

(246)

(232)

-

(232)

(455)‌‌

-

(455)‌‌

 

 

 

 

 

 

 

 

 

 

 

Profit on ordinary activitiesbefore taxation

 

232

3,915

4,147

326

2,911

3,237

1,675

2,019

3,694

Taxation on ordinary activities

 

-

-

-

(11)

11

-

(250)‌‌

250

-

 

 

 

 

 

 

 

 

 

 

 

Profit for the period, being total comprehensiveincome for the period

 

232

3,915

4,147

315

2,922

3,237

1,425

2,269

3,694

 

 

 

 

 

 

 

 

 

 

 

Return per ordinary share:

 

 

 

 

 

 

 

 

 

 

Basic

2

0.31p

5.21p

5.52p

0.44p

4.09p

4.53p

1.95p

3.10p

5.05p

 

 

 

 

 

 

 

 

 

 

 

 

All items in the above statement derive from continuing operations.

 

The revenue column of the Income Statement includes all income and expenses. The capital column accounts for the realised and unrealised profit or loss on investments and the proportion of the management fee charged to capital.

 

The total column of this statement is the Statement of Total Comprehensive Income of the Company prepared in accordance with Financial Reporting Standards ("FRS"). The supplementary revenue return and capital return columns are prepared in accordance with the Statement of Recommended Practice issued in November 2014 by the Association of Investment Companies ("AIC SORP").

 

Unaudited Statement of Changes in Equity

For the six months to 30 June 2015

 

 

 

Non-distributable reserves

Distributable reserves

 

 

 

 

Notes

Called-up share capital£'000

Share premium£'000

Otherreserve£'000

Revaluationreserve£'000

Capitalreserve£'000

Revenue reserve£'000

Total£'000

 

 

 

 

 

 

 

 

 

At 1 January 2015

 

8,463

8,813

33,716#

12,521

12,410

694

76,617

Movement between reserves

 

-

-

(33,716)

-

33,716

-

-

Profit/(loss) on ordinaryactivities after taxation

 

-

-

-

4,114

(199)

232

4,147

Buyback of shares to be held in treasury

4

-

-

-

-

(1,052)

-

(1,052)

 

 

 

 

 

 

 

 

 

At 30 June 2015

 

8,463

8,813

-

16,635

44,875

926

79,712

 

 

 

 

 

 

 

 

 

 

 

# On 18 December 2013 the court granted orders allowing the Company to cancel its share premium account and capital redemption reserve. The amounts of £22,866,000 (share premium) and £10,862,000 (capital redemption reserve) less costs paid became distributable during 2015.

 

 

For the six months to 30 June 2014

 

 

 

Non-distributable reserves

Distributable reserves

 

 

Notes

Called-up share capital£'000

Share premium£'000

Otherreserve£'000

Revaluation reserve£'000

Capitalreserve£'000

Revenue reserve£'000

Total£'000

 

 

 

 

 

 

 

 

 

At 1 January 2014

 

7,573

-

33,718

12,992

19,906

690

74,879

Profit on ordinaryactivities after taxation

 

-

-

-

2,612

310

315

3,237

Net proceeds of share issue

 

890

8,810

-

-

-

-

9,700

Other costs charged to capital

 

-

-

(2)

-

-

-

(2)

Dividends paid

6

-

-

-

-

(4,972)

(311)

(5,283)

 

 

 

 

 

 

 

 

 

At 30 June 2014

 

8,463

8,810

33,716

15,604

15,244

694

82,531

 

 

 

 

 

 

 

 

 

 

For the year to 31 December 2014

 

 

 

Non-distributable reserves

Distributable reserves

 

 

Notes

Called-up share capital£'000

Share premium£'000

Otherreserve£'000

Revaluation reserve£'000

Capitalreserve£'000

Revenue reserve£'000

Total£'000

 

 

 

 

 

 

 

 

 

At 1 January 2014

 

7,573

-

33,718

12,992

19,906

690

74,879

(Loss)/profit on ordinaryactivities after taxation

 

-

-

-

(471)

2,740

1,425

3,694

Net proceeds of share issue & sale of shares fromtreasury

 

890

8,813

-

-

378

-

10,081

Other costs charged to capital

 

-

-

(2)

-

-

-

(2)

Dividends paid

6

-

-

-

-

(10,614)

(1,421)

(12,035)

 

 

 

 

 

 

 

 

 

At 31 December 2014

 

8,463

8,813

33,716

12,521

12,410

694

76,617

 

 

 

 

 

 

 

 

 

 

Unaudited Balance Sheet

As at 30 June 2015

 

Notes

As at

30 June

2015

£'000

 

As at 30 June 2014

£'000

As at31 December 2014

£'000

 

 

 

 

 

 

 

 

Fixed assets

 

 

 

 

 

 

Unquoted investments

7

 29,210

 

27,068

 24,302

 

Traded on AIM

7

 24,841

 

26,748

 24,938

 

Collective investment vehicle

7

 8,493

 

7,537

 7,676

 

Listed interest bearing securities

7

 7,992

 

8,996

 9,494

 

Listed on LSE

 

 -

 

2,770

 -

 

Traded on ISDX

 

 -

 

502

 -

 

 

 

 

 

 

 

 

Investments

7

 70,536

 

73,621

66,410

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Debtors

 

 272

 

280

485

 

Cash at bank and on deposit

 

 9,516

 

9,254

10,323

 

 

 

 

 

 

 

 

 

 

 9,788

 

9,534

10,808

 

 

 

 

 

 

 

 

Creditors (amounts falling due within one year)

 

(612)

 

(624)

(601)‌‌

 

 

 

 

 

 

 

Net current assets

 

 9,176

 

8,910

10,207

 

 

 

 

 

 

 

 

Net assets

 

 79,712

 

82,531

76,617

 

 

 

 

 

 

 

 

Capital and reserves

 

 

 

 

 

 

Called-up share capital

 

 8,463

 

8,463

8,463

 

Share premium

 

 8,813

 

8,810

8,813

 

Other reserve

 

 -

 

33,716

33,716

 

Capital reserve

 

 44,875

 

15,244

12,410

 

Revaluation reserve

7

 16,635

 

15,604

12,521

 

Revenue reserve

 

 926

 

694

694

 

 

 

 

 

 

 

 

Equity shareholders' funds

 

 79,712

 

82,531

76,617

 

 

 

As at

30 June

2015

£'000

 

As at 30 June 2014

£'000

 

As at31 December

2014

£'000

 

 

 

 

 

 

 

 

Net asset value per share

 107.35

p

110.15

p

 101.72

p

Number of ordinary shares in circulation

 74,253,966

 

74,928,966

 

75,318,966

 

 

 

 

 

 

 

 

Treasury net asset value per share

 106.37

p

109.56

p

 100.98

p

Number of ordinary shares in circulation

 74,253,966

 

74,928,966

 

75,318,966

 

Number of ordinary shares held in treasury

 10,374,214

 

9,699,214

 

 9,309,214

 

Number of listed ordinary shares in issue

 84,628,180

 

84,628,180

 

84,628,180

 

Unaudited Statement of Cash Flows

For the six months to 30 June 2015

 

 

Sixmonths to 30 June 2015

£'000

Sixmonths to30 June2014

£'000

Year to31 December 2014£'000

 

 

 

 

 

 

Net cash (outflow)/inflow from operating activities

(407)

(402)‌‌

161

 

Net cash inflow/(outflow) from investing activities

648

(2,316)‌‌

4,561

 

Equity dividends paid

-

(5,283)‌‌

(12,035)‌‌

 

 

 

 

 

 

Net cash inflow/(outflow) before financing activities

241

(8,001)‌‌

(7,313)‌‌

 

Net cash (outflow)/inflow from financing activities

(1,048)

9,691

10,072

 

 

 

 

 

 

(Decrease)/increase in cash

(807)

1,690

2,759

 

 

 

 

 

 

Reconciliation of net cash inflow to movement in net cash

 

 

 

 

(Decrease)/increase in cash

(807)

1,690

2,759

 

Opening cash position

10,323

7,564

7,564

 

 

 

 

 

 

Closing cash at bank and on deposit

9,516

9,254

10,323

 

 

 

 

 

 

Reconciliation of profit on ordinary activities before taxation to net cash (outflow)/inflow from operating activities

 

 

 

 

Profit on ordinary activities before taxation

4,147

3,237

3,694

 

Gains on investments

(4,615)

(3,608)‌‌

(3,400)‌‌

 

Changes in working capital and other non-cash items

61

(31)‌‌

(133)‌‌

 

 

 

 

 

 

Net cash (outflow)/inflow from operating activities

(407)

(402)‌‌

161

 

 

 

 

 

 

 

Notes

 

1. The condensed financial statements for the six months to 30 June 2015 comprise the statements set out on pages 7 to 13 together with the related notes below. The Company applies UK Generally Accepted Accounting Principles in its annual financial statements, and is intending to adopt FRS 102 and the AIC's Statement of Recommended Practice issued in November 2014 for its financial year ending 31 December 2015. The condensed financial statements for the six months to 30 June 2015 have therefore been prepared in accordance with FRS 104 'Interim Financial Reporting'. The directors do not expect any significant changes to the Company's accounting policies as a result of the adoption of FRS 102. The accounts have therefore been prepared on the basis of the same accounting policies as set out in the Company's Annual Report and Financial Statements for the year ended 31 December 2014.

 

The comparative figures for the financial year ended 31 December 2014 are not the Company's statutory accounts for that financial year, but are based on those accounts, represented as necessary to comply with FRS 102. Those accounts have been reported on by the Company's auditor and delivered to the registrar of companies. The report of the auditor was (i) unqualified, (ii) did not include a reference to any matters to which the auditor drew attention by way of emphasis without qualifying their report, and (iii) did not contain a statement under section 498 (2) or (3) of the Companies Act 2006.

 

2. Return per share is based on a weighted average of 75,135,817 ordinary shares in issue (30 June 2014 - 71,390,122 ordinary shares; 31 December 2014 - 73,235,895 ordinary shares).

 

3. Earnings for the first six months to 30 June 2015 should not be taken as a guide to the results of the full financial year to 31 December 2015.

 

4. During the six months to 30 June 2015 the Company purchased 1,065,000 shares to be held in treasury. At 30 June 2015, the Company holds 10,374,214 ordinary shares in treasury. These shares may be re-issued below Net Asset Value as long as the discount at issue is narrower than the average discount at which the shares were bought back.

 

5. Excluding treasury shares, there were 74,253,966 ordinary shares in issue at 30 June 2015 (30 June 2014 - 74,928,966 ordinary shares; 31 December 2014 - 75,318,966 ordinary shares).

 

6. The interim dividend of 3.0p per share (2.7p capital, 0.3p revenue) will be paid on 18 September 2015 to shareholders on the register on 4 September 2015. The ex-dividend date is 3 September 2015.

 

During the year to 31 December 2014, the Company paid a first interim dividend on 7 March 2014 of 8.0p per share (7.53p capital, 0.47p revenue), a second interim dividend on 19 September 2014 of 4.5p per share (3.76p capital, 0.74p revenue) and a third interim dividend on 19 December 2014 of 4.5p per share (3.76p capital, 0.74p revenue).

 

7. All investments are initially recognised and subsequently measured at fair value. Changes in fair value are recognised in the Income Statement.

 

The methods of fair value measurement are classified into a hierarchy based on reliability of the information used to determine the valuation.

 

· Level a - Fair value is measured based on quoted prices in an active market.

· Level b - Fair value is measured based on directly observable current market prices or indirectly being derived from market prices.

· Level c -

i) Fair value is measured using a valuation technique that is based on data from an observable market or;

ii) Fair value is measured using a valuation technique that is not based on data from an observable market.

 

Level a

Level b

Level c (ii)

 

 

 

 

 

 

 

 

 

Listedinterest

bearing

securities

£'000

Traded

on AIM

£'000

Collective

investment

vehicle

£'000

Unquoted

£'000

Total

£'000

 

 

 

 

 

 

 

 

Opening book cost

9,494

17,697

3,525

23,173

53,889

 

Opening unrealised appreciation

-

7,241

4,151

1,129

12,521

 

 

 

 

 

 

 

 

Opening valuation

9,494

24,938

7,676

24,302

66,410

 

 

 

 

 

 

 

 

Movements in the period:

 

 

 

 

 

 

Purchases at cost

23,485

2,052

-

3,822

29,359

 

Sales - proceeds

(24,987)

(2,820)

-

(2,041)

(29,848

)

- realised gains on sales

-

324

-

149

473

 

Unrealised gains/(losses) realised during the period

-

1,520

-

(1,492)

28

 

(Decrease)/increase in unrealised appreciation

-

(1,173)

817

4,470

4,114

 

 

 

 

 

 

 

 

Closing valuation

7,992

24,841

8,493

29,210

70,536

 

 

 

 

 

 

 

 

Closing book cost

7,992

18,773

3,525

23,611

53,901

 

Closing unrealised appreciation

-

6,068

4,968

5,599

16,635

 

 

 

 

 

 

 

 

Closing valuation

7,992

24,841

8,493

29,210

70,536

 

 

 

 

 

 

 

 

Equity shares

-

24,841

8,493

9,246

42,580

 

Loan notes

-

-

-

19,964

19,964

 

Fixed income securities

7,992

-

-

-

7,992

 

 

 

 

 

 

 

 

Closing valuation

7,992

24,841

8,493

29,210

70,536

 

 

 

 

 

 

 

 

 

There has been no significant change in the risk analysis as disclosed in the Company's annual accounts.

 

8. The financial information contained in this half-yearly financial report does not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. The information for the year to 31 December 2014 has been extracted from the latest published audited financial statements. The audited financial statements for the year to 31 December 2014, which were unqualified, have been filed with the Registrar of Companies. No statutory accounts in respect of any period after 31 December 2014 have been reported on by the Company's auditors or delivered to the Registrar of Companies.

 

9. The Company has one reportable segment being investing in primarily a portfolio of UK growth businesses, whether unquoted or traded on AIM.

 

10. Copies of the half-yearly financial report will shortly be made available to shareholders and will also be available from the Registered Office of the Company at 100 Wood Street, London EC2V 7AN.

 

Principal Risks and Uncertainties

 

The Company's assets consist of equity and fixed interest investments, cash and liquid resources. Its principal risks are therefore market risk, credit risk and liquidity risk. Other risks faced by the Company include loss of approval as a Venture Capital Trust, investment performance, regulatory and compliance, legislation, economic, political and external factors and operational risks. These risks, and the way in which they are managed, are described in more detail in the Risk Matrix within the Strategic Report in the Company's Annual Report and Accounts for the year to 31 December 2014. The Company's principal risks and uncertainties have not changed materially since the date of that report.

 

Related Parties

 

Livingbridge VC LLP ('the Manager') manages the investments of the Company. The Manager also provides or procures the provision of secretarial, accounting, administrative and custodian services to the Company. Under the management agreement, the Manager receives a fee of 2.5 per cent per annum of the net assets of the Company. This is described in more detail under the heading the investment management agreement within the Strategic Report in the Company's Annual Report and Accounts for the year to 31 December 2014. During the period, the Company has incurred management fees of £933,000 (30 June 2014 - £929,000; 31 December 2014 - £1,842,000) and secretarial and accounting fees of £69,000 (30 June 2014 - £69,000; 31 December 2014 - £133,000) payable to the Manager.

 

Going Concern

 

After making enquiries, and bearing in mind the nature of the Company's business and assets, the Directors consider that the Company has adequate resources to continue in operational existence for the foreseeable future. In arriving at this conclusion, the Directors have considered the liquidity of the Company and its ability to meet obligations as they fall due for a period of at least twelve months from the date that these financial statements were approved. As at 30 June 2015, the Company held cash and readily realisable securities totalling £17,508,000. Cash flow projections have been reviewed and show that the Company has sufficient funds to meet both its contracted expenditure and its discretionary cash outflows in the form of the share buyback programme and dividend policy. The Company has no external loan finance in place and is therefore not exposed to any gearing covenants.

 

Corporate Information

 

Directors

Anthony Townsend‡

Gill Nott OBE^

Andrew Karney*

Ian Orrock

 

Secretary

Livingbridge VC LLP

 

Registered Office

100 Wood Street

London EC2V 7AN

 

Investment Manager

Livingbridge VC LLP

100 Wood Street

London EC2V 7AN

020 7506 5717

 

Registered Number

04115341

 

 

 

 

 

 

 

 

 

 

‡ Chairman

^ Audit and Risk Chairman

* Senior Independent Director

 

Registrars and Transfer Office

Computershare Investor Services PLC

The Pavilions

Bridgwater Road

Bristol BS99 6ZZ

Tel: 0800 923 1532

 

Brokers

Panmure Gordon & Co

One New Change

London EC4M 9AF

Tel: 020 7886 2500

 

Auditor

KPMG LLP

Saltire Court

20 Castle Terrace

Edinburgh EH1 2EG

 

Solicitors

Dickson Minto W.S.

Broadgate Tower

20 Primrose Street

London EC2A 2EW

 

VCT Status Adviser

Robertson Hare LLP

4-6 Staple Inn

London WC1V 7QH

 

Website

www.baronsmeadvct3.co.uk

 

National Storage Mechanism

 

A copy of the Half-yearly Report will be submitted shortly to the National Storage Mechanism ("NSM") and will be available for inspection at the NSM, which is situated at: www.hemscott.com/nsm.do.

 

 

END

 

 

Neither the contents of the Company's website not the contents of any website accessible from hyperlinks on this announcements (or any other website) is incorporated into, or forms part of, this announcement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR GGUAWRUPAGAR
Date   Source Headline
1st May 202411:11 amRNSTotal Voting Rights
29th Apr 20243:30 pmRNSNet Asset Value(s)
3rd Apr 20249:00 amRNSShare Allotment, Total Voting Rights, Offer Close
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSClose of Offer to New Applications
20th Mar 20248:02 amRNSCHANGE OF ALLOTMENT DATE & EXTENSION OF THE OFFER
19th Mar 20245:37 pmRNSClose of Offer to New Applications
18th Mar 20244:48 pmRNSDirector/PDMR Shareholding
18th Mar 20244:46 pmRNSDirector/PDMR Shareholding
14th Mar 20241:00 pmRNSIntention to Utilise Over-allotment Facility
6th Mar 20243:00 pmRNSNet Asset Value(s)
6th Mar 20241:46 pmRNSResult of AGM
1st Mar 202410:34 amRNSTotal Voting Rights
15th Feb 20242:00 pmRNSAllotment of Shares and Total Voting Rights
7th Feb 202410:00 amRNSNet Asset Value(s)
2nd Feb 20242:50 pmRNSDirector/PDMR Shareholding
1st Feb 20245:12 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNSTransaction in Own Shares
30th Jan 202412:03 pmRNSDirector/PDMR Shareholding
26th Jan 20242:30 pmRNSAllotment of Shares and Total Voting Rights
24th Jan 20245:00 pmRNSNet Asset Value(s)
24th Jan 20244:00 pmRNSNet Asset Value(s)
22nd Jan 20243:00 pmRNSOffer Update Extension of Early Bird Discount Date
19th Jan 20242:35 pmRNSIssue of Supplementary Prospectus
4th Jan 20243:46 pmRNSChange of allotment date
2nd Jan 202411:00 amRNSTotal Voting Rights
22nd Dec 20237:00 amRNSAnnual Financial Report
12th Dec 20235:46 pmRNSTransaction in Own Shares
6th Dec 20231:30 pmRNSNet Asset Value(s)
24th Nov 20231:26 pmRNSPublication of a Prospectus/Offer for Subscription
22nd Nov 20237:00 amRNSCompliance with Market Abuse Regulation ("MAR")
14th Nov 202310:05 amRNSUpdate on Offer for Subscription
6th Nov 20234:00 pmRNSNet Asset Value(s)
27th Oct 20231:30 pmRNSNet Asset Value(s)
2nd Oct 20234:02 pmRNSTotal Voting Rights
28th Sep 20235:52 pmRNSTransaction in Own Shares
25th Sep 202312:28 pmRNSDirector/PDMR Shareholding
25th Sep 202312:25 pmRNSDirector/PDMR Shareholding
13th Sep 20237:00 amRNSTransaction in Own Shares - Replacement
12th Sep 20235:28 pmRNSTransaction in Own Shares
5th Sep 202311:00 amRNSIntention to Fundraise
4th Aug 20234:00 pmRNSNet Asset Value(s)
1st Aug 20231:54 pmRNSTotal Voting Rights
27th Jul 20234:11 pmRNSTransaction in Own Shares
24th Jul 20232:00 pmRNSNet Asset Value(s)
3rd Jul 202311:25 amRNSTotal Voting Rights
20th Jun 20233:40 pmRNSTransaction in Own Shares
13th Jun 20237:00 amRNSHalf-yearly Report
6th Jun 20235:30 pmRNSNet Asset Value(s)
12th May 20237:00 amRNSCompliance with the Market Abuse Regulation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.